<DOC>
	<DOCNO>NCT00535548</DOCNO>
	<brief_summary>Aim study : Evaluation feasibility , safety potential effect stem cell chronic wound use pressure sore model . Clinical relevance : - Accelerated heal uncomplicated wound - Enhanced healing complicate ( chronic , non-healing ) wound Study design : - Prospective controlled phase I/II study - Cohort 5 patient pilot study , reevaluation Patients : - Para- tetraplegic patient sacral pressure sore grade III-IVA accord classification Daniel Seiler Methods : 1 . First surgical intervention : - Radical debridement pressure sore - Bone marrow harvest iliac crest - Isolation hematopoietic stem cell , aim gain &gt; 1 mio . CD 34+ cell per patient GMP condition 3 . Stem cell therapy ( 2 day ) - Injection stem cell suspension ( 50'000 CD 34+ cell 100 microliter saline per cm2 wound surface ) one half total wound surface cell-free saline half control 4 . Second surgical intervention ( 3-4 week ) : - Complete excision wound - Closure defect fasciocutaneous flap 5 . Evaluation wound healing : - Clinical - 3D laser image - Histology - Growth factor assay</brief_summary>
	<brief_title>Hematopoietic Stem Cell Therapy Chronic Wounds Using Pressure Sore Model</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>Para tetraplegic Sacral pressure sores Grade IIIIV accord classification Daniel Seiler Diabetes mellitus Peripheral vascular disease Coronary artery disease Smoking Steroids immunosuppressive drug Systemic autoimmune rheumatoid diseases HIV Hepatitis B/C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Chronic wound</keyword>
	<keyword>Pressure sore</keyword>
	<keyword>Hematopoietic stem cell</keyword>
	<keyword>Wound heal</keyword>
</DOC>